Back to search
FDAFDA · Food and drugs·Recall number Z-1853-2014

RT-5100 Refractor and RT-3100 Refractor; Distributed by MARCO Opthalmic: Manufactured by NIDEK CO., Ltd., Aichi, Japan. Instrument provides means of positioning spherical and cylindrical lenses, prisms and other optical devices in front of a subject's eyes for purpose of determining refractive error and binocular functions.

Published July 2, 2014 · Recall initiated: June 9, 2014

Summary

FDA records medical device Class II recall Z-1853-2014, published July 2, 2014 and initiated June 9, 2014. Recalling firm: Nidek Inc; Status: Terminated; Reported quantity: ~4,285 units RT-5100; 167 units of RT-3100; Lot: RT-5100 and RT-3100, various serial numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Near Point Chart Arm of RT 5100 and RT-3100 Refractors may lower spontaneously with potential for patient injury.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nidek Inc
Distributor
US distribution only.
Lot
RT-5100 and RT-3100, various serial numbers.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was RT-5100 Refractor and RT-3100 Refractor; Distributed by MARCO Opthalmic: Manufactured by NIDEK CO., Ltd., Aichi, Japan. Instrument provides means of positioning spherical and cylindrical lenses, prisms and other optical devices in front of a subject's eyes for purpose of determining refractive error and binocular functions. recalled?

Yes. FDA published recall Z-1853-2014 on July 2, 2014. Reported hazard: Near Point Chart Arm of RT 5100 and RT-3100 Refractors may lower spontaneously with potential for patient injury.

What should I do if I have this product?

Voluntary: Firm initiated · Letter